Catechol-o-methyltransferase inhibitors

Intervention

1 paper1 finding

MeSH D065098

  • 1 lab in 1 country
  • Funder: Jeju National University Hospital
  • Humans1

Outcomes

1

Restricted mean survival time

no changein humans1

1 study
  1. Catechol-o-methyltransferase inhibitors have no effect on restricted mean survival time in humans (ΔRMST, -1.64 months, 95% CI -4.25-0.97).

    Humanscompared with levodopa monotherapy in newly diagnosed Parkinson's disease5-yearn = 4,949

    Association of early adjunctive dopaminergic therapy and 5-year mortality in Parkinson's disease: A nationwide cohort study

    Parkinsonism & related disorders17 Aug 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 months